Major Depressive Disorder Schizophrenia
Conditions
Interventions
None listed
Sponsors
Department of Neuropsychiatry, Keio University School of Medicine
Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of major depressive disorder or schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 2. Capacity to provide informed consent 3. 18 years of age or older 4. Within 2 years of the first visit to participating sites
Exclusion criteria
Exclusion criteria: 1. History of organic mental disorder, intellectual disability, or epilepsy 2. Presence of unstable physical conditions 3. Significant suicidal risk, or other factors that raise safety concerns as judged by the patient's treating physician or study investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Duration of untreated illness (DUI) - Stigma: Social Impact Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patients - sociodemographic and clinical information - 25-item Resilience Scale - Three questions on religiosity - Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Non-Illness Version (FACIT-Sp Non-Illness) - WHOQOL-BREF - Japanese Adult Reading Test (JART) - Personal and Social Performance Scale (PSP) - Montgomery Asberg Depression Rating Scale (MADRS)[Major Depressive Disorder] or Positive and Negative Syndrome Scale (PANSS)[Schizophrenia] 2. Key person - sociodemographic and clinical information - 25-item Resilience Scale | — |
Countries
Japan,Europe
Contacts
Public ContactHiroyuki Uchida
Keio University School of Medicine Department of Neuropsychiatry
Outcome results
None listed